MedPath

上海天伟生物制药有限公司

Ownership
-
Established
2001-04-25
Employees
-
Market Cap
-
Website
http://www.techwell-cn.com/index.html

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

8

NMPA:8

Drug Approvals

Micafungin Sodium for Injection

Product Name
注射用米卡芬净钠
Approval Number
国药准字H20193323
Approval Date
Jun 12, 2024
NMPA

注射用尿促卵泡素

Approval Number
国药准字H20163050
Approval Date
Aug 27, 2020
NMPA

尿促卵泡素

Approval Number
国药准字H20052131
Approval Date
Jun 21, 2019
NMPA

尿促性素

Approval Number
国药准字H20053775
Approval Date
Jun 21, 2019
NMPA

普伐他汀钠

Approval Number
国药准字H20050455
Approval Date
Jun 21, 2019
NMPA

绒促性素

Approval Number
国药准字H20053778
Approval Date
Jun 20, 2019
NMPA

伏格列波糖

Approval Number
国药准字H20083811
Approval Date
Dec 7, 2017
NMPA

Latanoprost

Product Name
拉坦前列素
Approval Number
国药准字H20143332
Approval Date
Oct 17, 2014
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.